Clusterin inhibition using OGX-011 synergistically enhances zoledronic acid activity in osteosarcoma

PURPOSE: Despite recent improvements in therapeutic management of osteosarcoma, ongoing challenges in improving the response to chemotherapy warrants new strategies still needed to improve overall patient survival. Among new therapeutic approaches, zoledronic acid (ZOL) represents a promising adjuva...

Descripción completa

Detalles Bibliográficos
Autores principales: Lamoureux, Francois, Baud'huin, Marc, Ory, Benjamin, Guiho, Romain, Zoubeidi, Amina, Gleave, Martin, Heymann, Dominique, Rédini, Françoise
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4202162/
https://www.ncbi.nlm.nih.gov/pubmed/25138053

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4202162/
https://www.ncbi.nlm.nih.gov/pubmed/25138053

Ejemplares similares